Iwicki Mark T.

Insider Reports History

Identity
Location
Marlborough, MA
SEC record
Reporting signature
/s/ Mark Iwicki
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Iwicki Mark T.:

Form 4 holding Director

Q32 Bio Inc.

Security class
Stock Option (Right to Buy)
Shares / value
53,521
Estimated value
$342,666
Report date
23 Oct 2025
Price
$13.42
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Aerovate Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
12,500
Estimated value
$204,625
Report date
05 Jun 2024
Price
$16.37
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Merus N.V.

Security class
Share Option (right to buy)
Shares / value
0
Estimated value
$119,571
Report date
12 Dec 2025
Price
$13.52
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Director

KALA BIO, Inc.

Security class
Stock Option (right to buy)
Shares / value
5,450
Estimated value
Report date
15 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Iwicki Mark T.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .